Literature DB >> 6338030

Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory.

A L Truant, B L Barksdale, T W Huber, L B Elliott.   

Abstract

Comparative evaluations of immune status for rubella virus are described for enzyme-linked immunosorbent assay, hemagglutination inhibition, and indirect hemagglutination. A 92.1% agreement between enzyme-linked immunosorbent assay and indirect hemagglutination assay was demonstrated for rubella immune status. Enzyme-linked immunosorbent assay and hemagglutination inhibition demonstrated a 92.6% agreement and were compared in an attempt to define the quantitative usefulness of comparisons of single sera for determining immune status. These data support the relative lack of correlation between single enzyme-linked immunosorbent assay and hemagglutination inhibition quantitative values. Enzyme immunoassay was, however, an acceptable alternative to hemagglutination inhibition for the determination of immune status to rubella virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338030      PMCID: PMC272583          DOI: 10.1128/jcm.17.1.106-108.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies.

Authors:  B F Vestergaard; P C Grauballe
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-08

2.  A solid-phase enzyme-linked immunosorbent assay (ELISA) for detection of antibody to rubella virus.

Authors:  S M Garland; S A Locarnini; I D Gust
Journal:  Pathology       Date:  1979-07       Impact factor: 5.306

3.  Detection of rubella antibodies by hemagglutination inhibition, indirect fluorescent-antibody test, and enzyme-linked immunosorbent assay.

Authors:  M V Zartarian; G Friedly; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

4.  Comparison of hemagglutination inhibition test and enzyme-linked immunosorbent assay for determining antibody to rubella virus.

Authors:  I C Shekarchi; J L Sever; N Tzan; A Ley; L C Ward; D Madden
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

5.  A simple method for detecting antibodies to rubella.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1975-08

6.  Comparison of the sensitivity of ELISA and the haemagglutination-inhibition test for routine diagnosis of rubella.

Authors:  M Vejtorp; J Leerhoy
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-12
  6 in total
  9 in total

1.  Differences in antibody responses with rapid agglutination tests for the detection of rubella antibodies.

Authors:  M A Chernesky; D J DeLong; J B Mahony; S Castriciano
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

2.  Comparative evaluation of commercial rubella virus antibody kits.

Authors:  R A Wittenburg; M A Roberts; L B Elliott; L M Little
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

3.  Problems in determining immune status in borderline specimens in an enzyme immunoassay for rubella immunoglobulin G antibody.

Authors:  R S Steece; M S Talley; M R Skeels; G A Lanier
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

4.  Multicenter evaluation of a 1-h enzyme-linked immunosorbent assay for rubella serology.

Authors:  W L Boteler; K J Barnes; E Buimovici-Klein; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

5.  High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers.

Authors:  Nathaniel D Lambert; V Shane Pankratz; Beth R Larrabee; Adaeze Ogee-Nwankwo; Min-hsin Chen; Joseph P Icenogle; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

6.  Determination of immune status in patients with low antibody titers for rubella virus.

Authors:  S L Fayram; S Akin; S L Aarnaes; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  Use of enzyme immunoassays and the latex agglutination test to measure the temporal appearance of immunoglobulin G and M antibodies after natural infection or immunization with rubella virus.

Authors:  J M Meegan; B K Evans; D M Horstmann
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

8.  Evaluation of rubella immune status by three commercial enzyme-linked immunosorbent assays.

Authors:  P R Field; D W Ho; A L Cunningham
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

9.  Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

Authors:  Iana H Haralambieva; Michael J Gibson; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.